🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-525042-22-00
Completed Phase I

A Study to Evaluate the Safety and Activity of an Inhaled Investigational Drug (RO7616605) in Healthy Volunteers and Participants With COPD

2025-525042-22-00 · tracked via the Priya Life Science EU tracker
Sponsor
Genentech Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Respiratory Tract Diseases
Decision date
23/07/2026
Enrollment target
104
Sites
Germany

Condition studied

Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-525042-22-00 on CTIS ↗ ← All trials in the EU